Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22ClFN2O2 |
InChIKeyPGERJQKPSKSGLZ-GKBUVIDJSA-N |
CAS Registry2702268-02-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | United States | 22 Jul 2021 |